Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-09-01 | 2022-12-14 |
| Drug Identification Number | 02334852 | 02334852 |
| Brand name | NORDITROPIN NORDIFLEX | NORDITROPIN NORDIFLEX |
| Common or Proper name | NORDITROPIN NORDIFLEX | NORDITROPIN NORDIFLEX |
| Company Name | NOVO NORDISK CANADA INC | NOVO NORDISK CANADA INC |
| Ingredients | SOMATROPIN | SOMATROPIN |
| Strength(s) | 5MG | 5MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | EA | EA |
| ATC code | H01AC | H01AC |
| ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) | Demand increase for the drug. |
| Anticipated start date | 2023-06-01 | 2023-06-01 |
| Actual start date | 2023-06-08 | |
| Estimated end date | 2023-08-30 | 2023-08-30 |
| Actual end date | 2023-08-31 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Norditropin® FlexPro™ will be available for impacted 5 mg patients to transition to. For any questions or concerns, please contact our Customer Care at 1-800-465 4334. | Norditropin® NordiFlex® 15 mg will continue to be available to Canadian patients to ensure all patients currently taking Norditropin® can remain on treatment. |
| Health Canada comments |